Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myelo...
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
About this item
Full title
Author / Creator
Bachanova, V , Marks, D I , Zhang, M-J , Wang, H , de Lima, M , Aljurf, M D , Arellano, M , Artz, A S , Bacher, U , Cahn, J-Y , Chen, Y-B , Copelan, E A , Drobyski, W R , Gale, R P , Greer, J P , Gupta, V , Hale, G A , Kebriaei, P , Lazarus, H M , Lewis, I D , Lewis, V A , Liesveld, J L , Litzow, M R , Loren, A W , Miller, A M , Norkin, M , Oran, B , Pidala, J , Rowe, J M , Savani, B N , Saber, W , Vij, R , Waller, E K , Wiernik, P H and Weisdorf, D J
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The efficacy of reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT) for Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) is uncertain. We analyzed 197 adults with Ph+ ALL in first complete remission; 67 patients receiving RIC were matched with 130 receiving myeloablative conditioning (MA...
Alternative Titles
Full title
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
Authors, Artists and Contributors
Author / Creator
Marks, D I
Zhang, M-J
Wang, H
de Lima, M
Aljurf, M D
Arellano, M
Artz, A S
Bacher, U
Cahn, J-Y
Chen, Y-B
Copelan, E A
Drobyski, W R
Gale, R P
Greer, J P
Gupta, V
Hale, G A
Kebriaei, P
Lazarus, H M
Lewis, I D
Lewis, V A
Liesveld, J L
Litzow, M R
Loren, A W
Miller, A M
Norkin, M
Oran, B
Pidala, J
Rowe, J M
Savani, B N
Saber, W
Vij, R
Waller, E K
Wiernik, P H
Weisdorf, D J
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3951192
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3951192
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2013.253
